Srdjan Stankovic's most recent trade in Acadia Pharmaceuticals Inc was a trade of 6,250 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 19, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2022 | 6,250 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2022 | 6,250 | 63,081 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 19 Nov 2022 | 1,847 | 61,234 (0%) | 0% | 15.1 | 27,834 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 2,969 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 2,969 | 58,157 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 15.81 per share. | 15 Oct 2022 | 1,326 | 56,831 (0%) | 0% | 15.8 | 20,964 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 9,616 | 9,616 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 9,616 | 58,053 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 29 Apr 2022 | 2,865 | 55,188 (0%) | 0% | 18.2 | 52,091 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 144,695 | 144,695 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 124,138 | 124,138 | - | - | Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 36,174 | 36,174 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 4,919 | 14,758 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 4,919 | 49,938 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 23 Feb 2022 | 1,501 | 48,437 (0%) | 0% | 23.8 | 35,724 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 5,444 | 46,956 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 5,444 | 10,889 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 23.05 per share. | 06 Jan 2022 | 1,937 | 45,019 (0%) | 0% | 23.1 | 44,648 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 6,250 | 44,315 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 6,250 | 6,250 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 19 Nov 2021 | 2,803 | 41,512 (0%) | 0% | 19.0 | 53,285 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 2,969 | 39,403 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 2,969 | 2,969 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 17.41 per share. | 15 Oct 2021 | 1,338 | 38,065 (0%) | 0% | 17.4 | 23,295 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 9,615 | 40,664 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 9,615 | 19,232 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 29 Apr 2021 | 4,230 | 36,434 (0%) | 0% | 20.3 | 85,996 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 72,463 | 72,463 | - | - | Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 19,677 | 19,677 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 21,875 | 21,875 | - | - | Employee Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 19,231 | 39,478 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 15,625 | 15,625 | - | - | Employee Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 11,875 | 11,875 | - | - | Employee Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 50.61 per share. | 04 Feb 2021 | 8,429 | 31,049 (0%) | 0% | 50.6 | 426,592 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 55.01 per share. | 12 Jan 2021 | 700 | 20,247 (0%) | 0% | 55.0 | 38,507 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.12 per share. | 12 Jan 2021 | 700 | 20,947 (0%) | 0% | 18.1 | 12,684 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2021 | 700 | 89,562 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 55.12 per share. | 06 Jan 2021 | 61,619 | 20,247 (0%) | 0% | 55.1 | 3,396,187 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. | 06 Jan 2021 | 61,619 | 81,866 (0%) | 0% | 35.8 | 2,205,960 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 61,619 | 69,631 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 55.22 per share. | 06 Jan 2021 | 29,733 | 20,247 (0%) | 0% | 55.2 | 1,641,832 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 13,381 | 56,250 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. | 06 Jan 2021 | 13,381 | 33,628 (0%) | 0% | 35.8 | 479,040 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.28 per share. | 06 Jan 2021 | 12,864 | 46,492 (0%) | 0% | 21.3 | 273,746 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 12,864 | 22,761 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 5,444 | 21,972 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 5,444 | 16,333 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 3,488 | 90,262 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.12 per share. | 06 Jan 2021 | 3,488 | 49,980 (0%) | 0% | 18.1 | 63,203 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan R. Stankovic | President | Sale of securities on an exchange or to another person at price $ 53.34 per share. | 06 Jan 2021 | 1,725 | 20,247 (0%) | 0% | 53.3 | 92,012 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 6,250 | 12,500 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 6,250 | 19,256 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Sale of securities on an exchange or to another person at price $ 53.50 per share. | 19 Nov 2020 | 2,728 | 16,528 (0%) | 0% | 53.5 | 145,948 | Common Stock |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,969 | 14,303 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,969 | 5,938 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Srdjan Stankovic | President | Sale of securities on an exchange or to another person at price $ 42.56 per share. | 15 Oct 2020 | 1,297 | 13,006 (0%) | 0% | 42.6 | 55,200 | Common Stock |